OBJECTIVE: To determine the pregnancy outcomes associated with maternal chronic hypertension. STUDY DESIGN: Retrospective, population-based cohort study of maternal and infant discharge records linked to birth records in California from 1991 to 2001 were examined for demographics and pregnancy outcomes, and comparisons were made between those with and without chronic hypertension. One randomly selected pregnancy per subject was included. RESULTS: The number of women who delivered with chronic hypertension (0.69% incidence) was 29,842. As compared to non-chronic hypertensive patients, fetal and neonatal mortality and in-hospital maternal mortality were increased (ORs and 95% CIs 2.3, (2.1, 2.6); 2.3, (2.0, 2.7); and 4.8, (3.1, 7.6) respectively). Major maternal morbidity was increased: stroke, OR 5.3, (3.7, 7.5); renal failure, OR 6.0, (4.4, 8.1); pulmonary edema, OR 5.2, (3.9, 6.7); severe preeclampsia, OR 2.7, (2.5, 2.9); and placental abruption OR 2.1, (2.0, 2.3). Neonatal morbidity was increased as well: fetal growth restriction, OR 4.9, (4.7, 5.2); prematurity, OR 3.2, (3.1, 3.3); low birth weight, OR 5.4, (5.2, 5.5); very low birth weight, OR 6.5, (6.2, 6.8); and respiratory distress syndrome, OR 4.0, (3.8, 4.2). CONCLUSION: Pregnant women with chronic hypertension have significantly increased risks of maternal and perinatal morbidity and mortality. Women with this condition should be treated as high risk with appropriate maternal and fetal surveillance.
OBJECTIVE: To determine the pregnancy outcomes associated with maternal chronic hypertension. STUDY DESIGN: Retrospective, population-based cohort study of maternal and infant discharge records linked to birth records in California from 1991 to 2001 were examined for demographics and pregnancy outcomes, and comparisons were made between those with and without chronic hypertension. One randomly selected pregnancy per subject was included. RESULTS: The number of women who delivered with chronic hypertension (0.69% incidence) was 29,842. As compared to non-chronic hypertensivepatients, fetal and neonatal mortality and in-hospital maternal mortality were increased (ORs and 95% CIs 2.3, (2.1, 2.6); 2.3, (2.0, 2.7); and 4.8, (3.1, 7.6) respectively). Major maternal morbidity was increased: stroke, OR 5.3, (3.7, 7.5); renal failure, OR 6.0, (4.4, 8.1); pulmonary edema, OR 5.2, (3.9, 6.7); severe preeclampsia, OR 2.7, (2.5, 2.9); and placental abruption OR 2.1, (2.0, 2.3). Neonatal morbidity was increased as well: fetal growth restriction, OR 4.9, (4.7, 5.2); prematurity, OR 3.2, (3.1, 3.3); low birth weight, OR 5.4, (5.2, 5.5); very low birth weight, OR 6.5, (6.2, 6.8); and respiratory distress syndrome, OR 4.0, (3.8, 4.2). CONCLUSION: Pregnant women with chronic hypertension have significantly increased risks of maternal and perinatal morbidity and mortality. Women with this condition should be treated as high risk with appropriate maternal and fetal surveillance.
Authors: Joanna L Stanley; Irene J Andersson; Cassandra J Hirt; Linn Moore; Mark R Dilworth; Alejandro R Chade; Colin P Sibley; Sandra T Davidge; Philip N Baker Journal: Biol Reprod Date: 2012-07-26 Impact factor: 4.285
Authors: Michele L Okun; Christopher E Kline; James M Roberts; Barbara Wettlaufer; Khaleelah Glover; Martica Hall Journal: J Womens Health (Larchmt) Date: 2013-10-12 Impact factor: 2.681
Authors: Abbey B Berenson; Ali M Pohlmeier; Tabassum H Laz; Mahbubur Rahman; George Saade Journal: J Acad Nutr Diet Date: 2015-06-20 Impact factor: 4.910
Authors: Brian T Bateman; Pooja Bansil; Sonia Hernandez-Diaz; Jill M Mhyre; William M Callaghan; Elena V Kuklina Journal: Am J Obstet Gynecol Date: 2011-11-07 Impact factor: 8.661
Authors: E S Machado; C B Hofer; T T Costa; S A Nogueira; R H Oliveira; T F Abreu; L A Evangelista; I F A Farias; R T C Mercadante; M F L Garcia; R C Neves; V M Costa; J S Lambert Journal: Sex Transm Infect Date: 2008-11-05 Impact factor: 3.519
Authors: Erika F Werner; David A Savitz; Teresa M Janevic; Robert M Ehsanipoor; Stephen F Thung; Edmund F Funai; Heather S Lipkind Journal: Obstet Gynecol Date: 2012-09 Impact factor: 7.661
Authors: Amanda M Eudy; Anna Maria Siega-Riz; Stephanie M Engel; Nora Franceschini; Annie Green Howard; Megan E B Clowse; Michelle Petri Journal: J Rheumatol Date: 2018-07-15 Impact factor: 4.666
Authors: Shin Y Kim; Carina Saraiva; Michael Curtis; Hoyt G Wilson; Jennifer Troyan; Andrea J Sharma Journal: Am J Public Health Date: 2013-08-15 Impact factor: 9.308